Publication Date
| In 2025 | 0 |
| Since 2024 | 1 |
| Since 2021 (last 5 years) | 5 |
| Since 2016 (last 10 years) | 10 |
| Since 2006 (last 20 years) | 66 |
Descriptor
| Behavior Modification | 91 |
| Children | 91 |
| Drug Therapy | 91 |
| Adolescents | 37 |
| Intervention | 31 |
| Outcomes of Treatment | 31 |
| Symptoms (Individual… | 26 |
| Cognitive Restructuring | 23 |
| Behavior Problems | 22 |
| Attention Deficit Disorders | 18 |
| Autism | 18 |
| More ▼ | |
Source
Author
Publication Type
Education Level
| Adult Education | 1 |
| Elementary Education | 1 |
| Elementary Secondary Education | 1 |
| Grade 1 | 1 |
| Grade 10 | 1 |
| Grade 11 | 1 |
| Grade 2 | 1 |
| Grade 3 | 1 |
| Grade 4 | 1 |
| Grade 5 | 1 |
| Grade 7 | 1 |
| More ▼ | |
Location
| Canada | 2 |
| New York | 2 |
| Australia | 1 |
| Denmark | 1 |
| Indiana | 1 |
| Ireland | 1 |
| Netherlands | 1 |
| Spain | 1 |
| Texas | 1 |
| United Kingdom | 1 |
| United Kingdom (Great Britain) | 1 |
| More ▼ | |
Laws, Policies, & Programs
| Individuals with Disabilities… | 1 |
| Rehabilitation Act 1973… | 1 |
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkMorosohk, Ellie; Miltenberger, Raymond – Journal of Autism and Developmental Disorders, 2022
It is important for children to learn safety skills, especially involving dangerous stimuli such as medicine that can be found in almost every household. This study examined a generalization-enhanced behavioral skills training package to teach children with autism poison safety skills. Three children ages 4- to 10-years-old received generalization…
Descriptors: Child Safety, Poisoning, Hazardous Materials, Children
Shoaib, Azza; Cepeda, M. Soledad; Murray, Gayle; Ochs-Ross, Rachel – Journal of Autism and Developmental Disorders, 2022
We used real world data to summarize comorbidities and interventions among patients newly diagnosed with autism spectrum disorder (ASD). Data were derived from two claims-based US healthcare databases; Medicaid and Optum to construct a retrospective cohort of 36,000 patients. Attention-Deficit-Hyperactivity-Disorder (ADHD) was the most common…
Descriptors: Autism Spectrum Disorders, Comorbidity, Attention Deficit Hyperactivity Disorder, Emotional Disturbances
Orla O'Regan; Yvonne Doyle; Marguerite Murray; Vera J. C. McCarthy; Mohamad M. Saab – International Journal of Developmental Disabilities, 2024
Background: Challenging behaviours are common among children and adolescents with intellectual disabilities. Such behaviours often result in poor quality of life outcomes such as physical injury, difficulties with relationships and community integration. Aim: This systematic review aimed to synthesise evidence from studies that assessed the effect…
Descriptors: Behavior Problems, Behavior Modification, Children, Adolescents
Auberry, Kathy – Journal of Intellectual Disabilities, 2022
Autism Spectrum Disorder (ASD) is a multifaceted developmental disability requiring specialized supports. Due to the growing diagnoses of ASD, the demand for behavior treatment centers has also grown. These centers offer a wide range of beneficial services to children with ASD, including medication administration and management. While centers may…
Descriptors: Autism, Pervasive Developmental Disorders, Students with Disabilities, Community Programs
Lomas Mevers, Joanna; Call, Nathan A.; Gerencser, Kristina R.; Scheithauer, Mindy; Miller, Sarah J.; Muething, Colin; Hewett, Shannon; McCracken, Courtney; Scahill, Lawrence; McElhanon, Barbara O. – Journal of Autism and Developmental Disorders, 2020
Children with autism spectrum disorder (ASD) are often delayed in achieving bowel continence, resulting in negative outcomes. In this pilot trial, 20 children with ASD and encopresis were randomly assigned to multidisciplinary intervention for encopresis (MIE; n = 10) or a waitlist control group (n = 10). The MIE group was treated for constipation…
Descriptors: Autism, Pervasive Developmental Disorders, Behavior Modification, Intervention
Tompkins, Michael A.; Owen, Daniela J.; Shiloff, Nicole H.; Tanner, Litsa R. – APA Books, 2019
Obsessive-compulsive disorder (OCD), which can cause significant impairment in personal, social, and academic contexts, affects nearly half a million children in the United States. This step-by-step guide provides mental health professionals with an adaptable, evidence-based model that uses cognitive behavior therapy to treat pediatric OCD. The…
Descriptors: Cognitive Restructuring, Behavior Modification, Evaluation Methods, Intervention
Bayo-Tallón, Vanessa; Esquirol-Caussa, Jordi; Pàmias-Massana, Montserrat; Planells-Keller, Kalia; Cascos-Rodríguez, Ana; Palao-Vidal, Diego J. – SAGE Open, 2020
Attention-deficit/hyperactivity disorder (ADHD) is a neurobiological disorder. Common symptoms are inattention, hyperactivity, impulsivity, and executive functions deficit, often with comorbidities. Main treatment involves pharmacological and non-pharmacological therapies (cognitive-behavioral therapy, psycho-pedagogical programs). Emerging…
Descriptors: Attention Deficit Hyperactivity Disorder, Students with Disabilities, Intervention, Drug Therapy
Pharmacotherapy Adherence for Pediatric Anxiety Disorders: Predictors and Relation to Child Outcomes
Zehgeer, Asima; Ginsburg, Golda S.; Lee, Phyllis; Birmaher, Boris; Walkup, John; Kendall, Philip C.; Sakolsky, Dara; Peris, Tara – Child & Youth Care Forum, 2018
Background: Pharmacotherapy is considered an evidenced-based treatment for anxious youth. There is a need to better understand the relation between medication adherence and child outcomes. Objective: This study prospectively examined: (1) baseline predictors of adherence and (2) the relation between medication adherence and clinical outcomes in…
Descriptors: Drug Therapy, Anxiety, Adolescents, Correlation
Reurts, Eva Enneke; Troost, Pieter W.; Dinnissen, Mariken; Reijnen, Sam; Hoekstra, Pieter J.; Popma, Arne – Journal of Intellectual Disabilities, 2021
A retrospective chart study of patients on open-label aripiprazole treatment was conducted in the Netherlands to add to the knowledge of aripiprazole in children and young adults with mild and borderline intellectual disabilities (IDs). Fifty-three youths, mean age 14.7 ± 3.4 years and mean IQ 64.5 ±13.8, were included. Treatment responders were…
Descriptors: Mild Intellectual Disability, Drug Therapy, Outcomes of Treatment, Foreign Countries
Riccio, Cynthia A.; Pliego, Jessica; Rae, William A. – International Journal of School & Educational Psychology, 2016
An increasing number of children experience chronic health issues that affect their academic and behavioral functioning, as well as psychological well-being. At the same time, psychological stress can exacerbate the chronic illness. The first line of treatment most often is medical (e.g., pharmacology, surgery, radiation). Even when the medical…
Descriptors: Chronic Illness, Metacognition, Intervention, Well Being
Roy, A.; Roy, M.; Deb, S.; Unwin, G.; Roy, A. – Journal of Intellectual Disability Research, 2015
Background: ASC (autism spectrum conditions) may result from a failure of striatal beta endorphins to diminish with maturation. Many symptoms of ASC resemble behaviours induced in animals or humans by opiate administration, including decreased socialisation, diminished crying, repetitive stereotypies, insensitivity to pain and motor hyperactivity.…
Descriptors: Autism, Pervasive Developmental Disorders, Drug Therapy, Behavior Problems
Bloch, Michael H.; Panza, Kaitlyn E.; Grant, Jon E.; Pittenger, Christopher; Leckman, James F. – Journal of the American Academy of Child & Adolescent Psychiatry, 2013
Objective: To examine the efficacy of N-acetylcysteine (NAC) for the treatment of pediatric trichotillomania (TTM) in a double-blind, placebo-controlled, add-on study. Method: A total of 39 children and adolescents aged 8 to 17 years with pediatric trichotillomania were randomly assigned to receive NAC or matching placebo for 12 weeks. Our primary…
Descriptors: Outcome Measures, Depression (Psychology), Anxiety, Drug Therapy
Caporino, Nicole E.; Brodman, Douglas M.; Kendall, Philip C.; Albano, Anne Marie; Sherrill, Joel; Piacentini, John; Sakolsky, Dara; Birmaher, Boris; Compton, Scott N.; Ginsburg, Golda; Rynn, Moira; McCracken, James; Gosch, Elizabeth; Keeton, Courtney; March, John; Walkup, John T. – Journal of the American Academy of Child & Adolescent Psychiatry, 2013
Objective: To determine optimal Pediatric Anxiety Rating Scale (PARS) percent reduction and raw score cut-offs for predicting treatment response and remission among children and adolescents with anxiety disorders. Method: Data were from a subset of youth (N = 438; 7-17 years of age) who participated in the Child/Adolescent Anxiety Multimodal Study…
Descriptors: Rating Scales, Anxiety Disorders, Raw Scores, Child Health
Hollway, Jill A.; Aman, Michael G. – Research in Developmental Disabilities: A Multidisciplinary Journal, 2011
Sleep disturbance is a common problem in children with developmental disabilities. Effective pharmacologic interventions are needed to ameliorate sleep problems that persist when behavior therapy alone is insufficient. The aim of the present study was to provide an overview of the quantity and quality of pharmacologic research targeting sleep in…
Descriptors: Developmental Disabilities, Behavior Modification, Sleep, Drug Therapy
Sarwer, David B.; Dilks, Rebecca J. – Journal of Youth and Adolescence, 2012
The prevalence of childhood and adolescent obesity has tripled in the past three decades. This increase has been accompanied by a dramatic rise in obesity-related health complications among American youth. Thus, many obese youth are now experiencing illnesses that will threaten their life expectancy in the absence of significant weight loss.…
Descriptors: Obesity, Mental Health Workers, Mental Health, Surgery
